SCHEMBL20166236

SCHEMBL20166236

O=C(O)[C@@H](O)Cc1ccc(SC(F)(F)F)cc1

nearest known ligand 0.49

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PTPRZ1 P23471 4/20 0.49
KDM6B O15054 1/20 0.47
PTPN1 P18031 2/20 0.47
EPHX2 P34913 1/20 0.43
NR1H4 Q96RI1 1/20 0.43
ALDH1A1 P00352 2/20 0.41
KDM4E B2RXH2 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
GRB2 P62993 1/20 0.40
KIF11 P52732 1/20 0.40
KCNK2 O95069 4/20 0.38
KCNK10 P57789 3/20 0.38
GCGR P47871 1/20 0.38
GIPR P48546 1/20 0.38
MAPT P10636 1/20 0.38
ATM Q13315 1/20 0.38
CPA1 P15085 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20166238 1.00 PTPRZ1 (0.49) PTPRZ1KDM6BPTPN1EPHX2NR1H4
SCHEMBL20166265 0.82 GRB2 (0.60) PTPRZ1PTPN1ALDH1A1KDM4ETDP1
SCHEMBL12439873 0.82 GRB2 (0.60) PTPRZ1PTPN1ALDH1A1KDM4ETDP1
SCHEMBL29771361 0.80 PTPRZ1 (0.46) PTPRZ1PTPN1ALDH1A1TDP1KCNK2
SCHEMBL10891346 0.80 KDM6B (0.67) KDM6B
SCHEMBL18248013 0.77 PPARG (0.53) KDM6BPTPN1EPHX2GRB2
SCHEMBL10170597 0.77 PPARG (0.53) KDM6BPTPN1EPHX2GRB2
SCHEMBL963353 0.75 PTPRZ1 (0.63) PTPRZ1PTPN1EPHX2NR1H4ALDH1A1
SCHEMBL18247995 0.75 PTPN1 (0.55) KDM6BPTPN1EPHX2NR1H4GCGR
SCHEMBL20586417 0.75 PTPN1 (0.55) KDM6BPTPN1EPHX2NR1H4GCGR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11382949-B2 Anthelmintic depsipeptide compounds Boehringer Ingelheim Animal Health USA Inc. (US) 2022-07-12 US disclosed
US-20190307838-A1 ANTHELMINTIC DEPSIPEPTIDE COMPOUNDS Boehringer Ingelheim Animal Health USA Inc. (US) 2019-10-10 US disclosed
EP-3541789-A1 ANTHELMINTIC DEPSIPEPTIDE COMPOUNDS Boehringer Ingelheim Animal Health USA Inc. (US) 2019-09-25 EP disclosed
CN-110167921-A ANTHELMINTIC DEPSIPEPTIDE COMPOUNDS 勃林格殷格翰动物保健美国公司 2019-08-23 CN disclosed
WO-2018093920-A1 ANTHELMINTIC DEPSIPEPTIDE COMPOUNDS MERIAL, INC. (US) 2018-05-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11382949-B2 Anthelmintic depsipeptide compounds ENPP2, ROCK2, RRP12 PTPRZ1 1876/4885KDM6B 2032/4885PTPN1 849/4885
US-20190307838-A1 ANTHELMINTIC DEPSIPEPTIDE COMPOUNDS ENPP2, ROCK2, RRP12 PTPRZ1 1876/4885KDM6B 2032/4885PTPN1 849/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.